- Citations, last 5 years
- 11
- Works, last 5 years
- 15
- h-index
- 16
- Scientists listed
- 0
- Grants since 2016
- 248
Grants received
2018–2020 · research · R21
Molecular Mechanisms of Synaptic Aging
Sathya Puthanveettil · Scripps (United States) · funded by National Institutes of Health
2018–2023 · research · R01
Chemical, structural and molecular rules for fully antagonizing the estrogen receptor
Benita S Katzenellenbogen · Scripps (United States) · funded by National Institutes of Health
2018–2020 · research · R21
Validation of Siglec-6 as a novel target for cancer immunotherapy
Natarajan Muthusamy · Scripps (United States) · funded by National Institutes of Health
2018–2022 · research · R01
Phenotypic screening using DNA-encoded libraries
Thomas J. Kodadek · Scripps (United States) · funded by National Institutes of Health
2018–2023 · research · R01
Chemical, structural and molecular rules for fully antagonizing the estrogen receptor
Benita S Katzenellenbogen · Scripps (United States) · funded by National Institutes of Health
2018–2021 · fellowship · F32
Regulation of energy expenditure through BDNF neurons in the paraventricular hypothalamus
Shaw-Wen Wu · Scripps (United States) · funded by National Institutes of Health
2018–2022 · research · R01
Early development of small molecule neuroprotectants.
Thomas D Bannister · Scripps (United States) · funded by National Institutes of Health
2018–2022 · research · R35
Biocatalytic C -H Functionalization Logic in the Chemoenzymatic Synthesis of Therapeutic Natural Products
Hans Renata · Scripps (United States) · funded by National Institutes of Health
2018–2021 · research · R00
Intratumor heterogeneity and therapeutic resistance
Michalina Janiszewska · Scripps (United States) · funded by National Institutes of Health
2018–2019 · research · R33
Advanced Development and Validation of 3 Dimensional Spheroid Culture of Primary Cancer Cells using Nano3D Technology
Timothy Patrick Spicer · Scripps (United States) · funded by National Institutes of Health
2018–2021 · research · R01
Genetic analysis of a truncated insulin receptor.
Matthew Simon Gill · Scripps (United States) · funded by National Institutes of Health
2018–2022 · research · R01
Early development of small molecule neuroprotectants.
Thomas D Bannister · Scripps (United States) · funded by National Institutes of Health
2018–2021 · research · R00
Chemical editing of nanoscale proteoglycan architecture and organization to control cellular
Mia L Huang · Scripps (United States) · funded by National Institutes of Health
2018 · research · R01
Therapeutic Targeting of Casein Kinase-1-delta in Primary and Metastatic Breast Cancer
John L. Cleveland · Scripps (United States) · funded by National Institutes of Health
2018–2022 · research · R01
Redox Modification and Targeting of Mutant KRas in Cancer
Kate Suzanne Carroll · Scripps (United States) · funded by National Institutes of Health
2018–2022 · research · R01
A Clinical Indications Prediction (CLIP) Scale for Human Mesenchymal Stem Cells
Donald G Phinney · Scripps (United States) · funded by National Institutes of Health
2018–2023 · research · R35
Biocatalytic C -H Functionalization Logic in the Chemoenzymatic Synthesis of Therapeutic Natural Products
Hans Renata · Scripps (United States) · funded by National Institutes of Health
2018–2021 · research · R00
Intratumor heterogeneity and therapeutic resistance
Michalina Janiszewska · Scripps (United States) · funded by National Institutes of Health
2018–2022 · research · R01
Parallel Multimodal High-throughput screening to identify activators of the orexin receptors
Theodore M Kamenecka · Scripps (United States) · funded by National Institutes of Health
2018–2022 · research · R01
Redox Modification and Targeting of Mutant KRas in Cancer
Kate Suzanne Carroll · Scripps (United States) · funded by National Institutes of Health
2018–2021 · research · R21
Development and validation of small molecules to treat neurofibromatosis associated schwannoma
Thomas D Bannister · Scripps (United States) · funded by National Institutes of Health
2018–2021 · research · R01
Parallel Multimodal High-throughput screening to identify activators of the orexin receptors
Theodore M Kamenecka · Scripps (United States) · funded by National Institutes of Health
2018–2020 · fellowship · F31
Chemical approaches for precise recognition of a toxic RNA repeat
Alicia Jeannine Angelbello · Scripps (United States) · funded by National Institutes of Health
2018–2021 · research · R00
Intratumor heterogeneity and therapeutic resistance
Michalina Janiszewska · Scripps (United States) · funded by National Institutes of Health
2018–2023 · research · R01
Dynein-Dynactin Complex Mediated Retrograde Transport during Long-term Memory Storage
Sathya Puthanveettil · Scripps (United States) · funded by National Institutes of Health
2018–2019 · grant · S10
Kinetic Imaging Plate Reader
Timothy Patrick Spicer · Scripps (United States) · funded by National Institutes of Health
2017–2019 · career development · K25
Microfluidic High-Throughput Droplet-Scale Screening of DNA-Encoded Compound Libraries for Activators of the Bacterial Target ClpP
Alexander K Price · Scripps (United States) · funded by National Institutes of Health
2017–2022 · research · R01
Optimizing eCD4-Ig for eradication and a functional cure
Michael R. Farzan · Scripps (United States) · funded by National Institutes of Health
2017–2020 · grant · Continuing Grant
REU Site: SURFing the Interface between Chemistry and Biology
Katrin Karbstein · Scripps (United States) · funded by National Science Foundation
2017–2019 · research · R36
Functional circuitry supporting PTSD-like symptoms in male and female mice
Nadine Florence Joseph · Scripps (United States) · funded by National Institutes of Health
2017–2019 · research · R21
Polarization-Activated Droplet Sorting
Brian M Paegel · Scripps (United States) · funded by National Institutes of Health
2017–2022 · research · R01
Optimizing eCD4-Ig for eradication and a functional cure
Michael R. Farzan · Scripps (United States) · funded by National Institutes of Health
2017–2024 · research · R01
Integrated Platform for Discovery and Validation of Probes that Restore Protein Expression in Single-Gene Causes of Autism and Related Disorders
Courtney A Miller · Scripps (United States) · funded by National Institutes of Health
2017–2022 · research · R01
Optimizing eCD4-Ig for eradication and a functional cure
Michael R. Farzan · Scripps (United States) · funded by National Institutes of Health
2017–2020 · research · R01
Limiting undesirable effects of opioids by targeting neuronal RGS complexes
Kirill A. Martemyanov · Scripps (United States) · funded by National Institutes of Health
2017–2019 · research · R21
Development and validation of a genetically engineered model of neurofibromatosis type 2 to facilitate discovery of neurotherapeutics
Joseph Kissil · Scripps (United States) · funded by National Institutes of Health
2017–2020 · research · R21
Genetic and Molecular Analysis of a Novel Insulin Regulatory Protein
Matthew Simon Gill · Scripps (United States) · funded by National Institutes of Health
2017–2019 · research · R21
The role of spin genes in autophagy and lifespan in C. elegans
Matthew Simon Gill · Scripps (United States) · funded by National Institutes of Health
2017–2022 · research · R01
Optimizing eCD4-Ig for eradication and a functional cure
Michael R. Farzan · Scripps (United States) · funded by National Institutes of Health
2017–2022 · research · R01
Optimizing eCD4-Ig for eradication and a functional cure
Michael R. Farzan · Scripps (United States) · funded by National Institutes of Health
